Obatala Sciences, a New Orleans company that helps pharmaceutical companies bring new drugs to market faster than through conventional testing, has received an investment from an Ochsner Health-related investment group aimed at turbocharging its growth.
Obatala said Thursday that it had received "a major financial investment" from the Healthcare Innovation Fund II, whose investors include Ochsner Health, Ochsner Lafayette General, Acadian Companies and the William C. Schumacher Family Foundation.
The fund targets investments in firms that have proved their technology and are at a fast-growth stage.
The amount of the investment wasn't disclosed and a spokesperson for the fund wasn't available for comment.
Related Keywords
Ochsner Lafayette ,Williamc Schumacher Family Foundation ,Obatala Sciences ,Ochsner Health ,Tulane University ,Orleans Bioinnovation Center ,Healthcare Innovation Fund ,Acadian Companies ,New Orleans ,Ochsner Health Related ,Ochsner Lafayette General ,New Orleans Bioinnovation Center ,Canal Street ,Advanced Materials Research Institute ,New Orlean ,ஓசஸ்னெர் லாஃபாயெட் ,ஓசஸ்னெர் ஆரோக்கியம் ,துலேன் பல்கலைக்கழகம் ,சுகாதாரம் கண்டுபிடிப்பு நிதி ,அகேடியன் நிறுவனங்கள் ,புதியது ஆர்லீயந்ஸ் ,ஓசஸ்னெர் ஆரோக்கியம் தொடர்புடையது ,ஓசஸ்னெர் லாஃபாயெட் ஜநரல் ,கால்வாய் தெரு ,புதியது ஒரில்ேன் ,
comparemela.com © 2020. All Rights Reserved.